Difference between revisions of "Template:Hormone levels with polyestradiol phosphate by intramuscular injection"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Monkbot m (Task 18a (cosmetic) (manual): eval 2 templates: del empty params (3×);) |
||
| Line 4: | Line 4: | ||
| align=center | | align=center | ||
| style="font-size:small;" | | style="font-size:small;" | ||
| − | | File:Estradiol and testosterone levels with a single intramuscular injection of 320 mg polyestradiol phosphate in men.png | Estradiol and testosterone levels with a single intramuscular injection of 320 mg polyestradiol phosphate in men with prostate cancer.<ref name="pmid8610057">{{cite journal | vauthors = Stege R, Gunnarsson PO, Johansson CJ, Olsson P, Pousette A, Carlström K | title = Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients | journal = Prostate | volume = 28 | issue = 5 | pages = 307–10 | date = May 1996 | pmid = 8610057 | doi = 10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8 | + | | File:Estradiol and testosterone levels with a single intramuscular injection of 320 mg polyestradiol phosphate in men.png | Estradiol and testosterone levels with a single intramuscular injection of 320 mg polyestradiol phosphate in men with prostate cancer.<ref name="pmid8610057">{{cite journal | vauthors = Stege R, Gunnarsson PO, Johansson CJ, Olsson P, Pousette A, Carlström K | title = Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients | journal = Prostate | volume = 28 | issue = 5 | pages = 307–10 | date = May 1996 | pmid = 8610057 | doi = 10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8 }}</ref> |
| − | | File:Estradiol and testosterone levels with polyestradiol phosphate in men with prostate cancer.png | Estradiol and testosterone levels with polyestradiol phosphate 160, 240, or 320 mg once every 4 weeks by intramuscular injection in men with prostate cancer.<ref name="pmid3242384">{{cite journal | vauthors = Stege R, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A | title = Single drug polyestradiol phosphate therapy in prostatic cancer | journal = Am. J. Clin. Oncol. | volume = 11 Suppl 2 | + | | File:Estradiol and testosterone levels with polyestradiol phosphate in men with prostate cancer.png | Estradiol and testosterone levels with polyestradiol phosphate 160, 240, or 320 mg once every 4 weeks by intramuscular injection in men with prostate cancer.<ref name="pmid3242384">{{cite journal | vauthors = Stege R, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A | title = Single drug polyestradiol phosphate therapy in prostatic cancer | journal = Am. J. Clin. Oncol. | volume = 11 Suppl 2 | pages = S101–3 | date = 1988 | pmid = 3242384 | doi = 10.1097/00000421-198801102-00024 }}</ref> |
}}}}<!-- | }}}}<!-- | ||
Latest revision as of 20:14, 19 December 2020
- Hormone levels with polyestradiol phosphate by intramuscular injection
- Estradiol and testosterone levels with a single intramuscular injection of 320 mg polyestradiol phosphate in men.png
Estradiol and testosterone levels with a single intramuscular injection of 320 mg polyestradiol phosphate in men with prostate cancer.[1]
- Estradiol and testosterone levels with polyestradiol phosphate in men with prostate cancer.png
Estradiol and testosterone levels with polyestradiol phosphate 160, 240, or 320 mg once every 4 weeks by intramuscular injection in men with prostate cancer.[2]
50px Template documentation
References
- ↑ Stege R, Gunnarsson PO, Johansson CJ, Olsson P, Pousette A, Carlström K (May 1996). "Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients". Prostate. 28 (5): 307–10. doi:10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8. PMID 8610057.
- ↑ Stege R, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A (1988). "Single drug polyestradiol phosphate therapy in prostatic cancer". Am. J. Clin. Oncol. 11 Suppl 2: S101–3. doi:10.1097/00000421-198801102-00024. PMID 3242384.
| Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Subpages of this template. |